{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:51:13Z","timestamp":1773694273099,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>Direct-acting antivirals (DAAs) have been approved for treating chronic hepatitis C virus (HCV) in children and adolescents. Although DAAs have been used in real-world settings for the treatment of HCV monoinfected adolescents, few reports of real-world use of DAAs in children and adolescents who are coinfected with human immunodeficiency virus (HIV) are available. We evaluated the real-world safety and effectiveness of DAAs in HIV\/HCV coinfected adolescents from the Ukraine Paediatric HIV Cohort Study including all those for whom treatment outcomes were available by April 2021. Overall, 6 coinfected adolescents had received DAA treatment; 4 with sofosbuvir\/ledipasvir (SOF\/LDV), 1 with SOF\/LDV+ribavirin, and 1 with SOF\/daclatasvir. No patient discontinued treatment due to adverse events and no serious adverse events were reported. All 6 patients achieved sustained virologic response by 12 weeks after the end of therapy. DAA treatment was well tolerated and effective in adolescents with HIV\/HCV coinfection in a real-world setting.<\/jats:p>","DOI":"10.1097\/inf.0000000000003467","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T10:00:41Z","timestamp":1643018441000},"page":"417-419","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis C Virus Treatment Response to Direct-acting Antivirals Among Adolescents With HIV\/HCV Coinfection: Real-world Data From Ukraine"],"prefix":"10.1097","volume":"41","author":[{"given":"Farihah","family":"Malik","sequence":"first","affiliation":[{"name":"UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruslan","family":"Malyuta","sequence":"additional","affiliation":[{"name":"Perinatal Prevention of AIDS Initiative, Odessa, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Volokha","sequence":"additional","affiliation":[{"name":"Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Bailey","sequence":"additional","affiliation":[{"name":"Institute for Global Health, University College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intira Jeannie","family":"Collins","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Thorne","sequence":"additional","affiliation":[{"name":"UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Ukraine Paediatric HIV Cohort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(19)30046-9","article-title":"Hepatitis C virus infection in children and adolescents.","volume":"4","author":"Indolfi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"100227","DOI":"10.1016\/j.jhepr.2021.100227","article-title":"Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines.","volume":"3","author":"Malik","year":"2021","journal-title":"JHEP Rep"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S2055-6640(20)30504-5","article-title":"HCV treatment in children and young adults with HIV\/HCV co-infection in Europe.","volume":"1","author":"Turkova","year":"2015","journal-title":"J Virus Erad"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/QAD.0000000000001285","article-title":"Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe.","volume":"31","author":"Thorne","year":"2017","journal-title":"AIDS"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/QAI.0000000000002541","article-title":"Effectiveness and safety of interferon-free direct-acting antiviral Hepatitis C virus therapy in HIV\/Hepatitis C virus coinfected Individuals: results from a Pan-European Study.","volume":"86","author":"Amele","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MPG.0000000000000895","article-title":"Hepatitis C in children co-infected with human immunodeficiency virus.","volume":"61","author":"Indolfi","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jvh.13308","article-title":"Response to direct-acting antivirals for hepatitis C treatment in vertically HIV\/HCV co-infected patients.","volume":"27","author":"Carrasco","year":"2020","journal-title":"J Viral Hepat"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/liv.14308","article-title":"Effects of sofosbuvir\/ledipasvir therapy on chronic hepatitis C virus genotype 4, infected children of 3-6 years of age.","volume":"40","author":"Kamal","year":"2020","journal-title":"Liver Int"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MPG.0000000000002900","article-title":"Efficacy of Sofosbuvir\/Ledipasvir in adolescents with chronic hepatitis C genotypes 1, 3, and 4: A Real-world Study.","volume":"72","author":"Serranti","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R11-20250615","first-page":"1","article-title":"Effective treatment of chronic hepatitis C virus infection with Ledipasvir\/Sofosbuvir in 2 teenagers with HIV coinfection.","author":"Pokorska-\u015apiewak","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL recommendations on treatment of hepatitis C 2016.","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018.","volume":"69","year":"2018","journal-title":"J Hepatol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:02:44Z","timestamp":1750003364000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003467","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}